News

Study may help boost performance and reduce side effects of mRNA vaccines

Posted: 29 October 2024 A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research aimed to…

$55 million to scale up Aussie innovations

Posted: 29 October 2024 The Albanese Government is backing Australian business and science, funding world-leading innovations that can help transform Australian industry. More than $55 million in grants for projects working in critical minerals, renewable energy and other…

Seaport Therapeutics secures US$225 Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology

Posted: 29 October 2024 The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the closing of an oversubscribed US$225 million Series B financing round. The funding syndicate was…

Monash University co-leads international team to develop innovative new approach to treating stroke

Posted: 29 October 2024 Monash University and Yale University, USA, have together received $4M AUD in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS),…

New Alzheimer’s disease blood test shown to work on widely available pathology equipment

Posted: 29 October 2024 Florey researchers – with Australian research volunteers – have evaluated a new diagnostic blood test for Alzheimer’s and found it to be a reliable measure of the disease’s presence and stage. Plasma pTau217 blood…

FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

Posted: 29 October 2024 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging of glioma. The application has been…

4DMedical Secures $1.9M Grant to Ramp-up Trials for ‘Safer, Cheaper’ Lung Imaging

Posted: 29 October 2024 4DMedical has been awarded $1.9 million from the Federal Government under the latter’s CRC-P (Cooperative Research Centres Projects) grant program to fund its expansion and ramp-up of clinical trials for CT:VQ, being run in…

Investigations into lung cancer and into epigenetics recognised with 2 x $1.25 million CSL Centenary Fellowships

Posted: 29 October 2024 Two Australian scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. The Fellowships were presented at the Australian Academy of Health and Medical Sciences Annual Meeting on Thursday…

Masterclass agenda – Vital ventures: Scaling healthtech with sustainable strategies

    Part A | Tuesday 26 November 2024 BioForum – Biotech scandal to SaaS Success: Fireside chat with Theranos ’survivor’ Marissa Senzaki 03:45 PM Guest arrival and registration

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial

Posted: 21 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the first part (Part A, single dose) of the…

MTPConnect Cements US Medtech Links Through MoU with Influential Medical Alley

Posted: 21 October 2024 MTPConnect, Australia’s life science innovation accelerator, and Medical Alley, headquartered in Minnesota have committed to ongoing collaboration to support the growth of medtech companies with the signing today of a Memorandum of Understanding.  The…

$22 million investment in cancer clinical trials to save lives throughout Australia

Posted: 21 October 2024 The Minister for Health and Aged Care, the Hon Mark Butler MP, today announced the successful applicants for the 2024-2027 Support for Cancer Clinical Trials (Clinical Trials) program, with a total of $22.19 million…

Home

News & opinion

Member Directory

Events